Joincare Pharmaceutical Group Industry Co. Ltd. provided preliminary earnings guidance for the year 2018. For the year, the company predicts a decrease of between RMB 1,382,000,000 and RMB 1,446,000,000 in its net profit owned by shareholders of the listed company in 2018 compared with the same period of the year before, with a year-on-year decrease of between 64.77% and 67.78% (based on the disclosed statistics according to relevant regulations). The net profit belonging to shareholders of the listed company after excluding extraordinary profit and loss will increase by between RMB 114,000,000 and RMB 179,000,000 compared with the same period of the year before, with a year-on-year increase of between 22.87% and 35.75% (based on the disclosed statistics according to relevant regulations).